The present invention aims to provide an agent for preventing or ameliorating stress disorders, which agent is highly safe and effective, causes less side effects, and can be continuously used for a long time.

One embodiment of the present invention is an agent for preventing or ameliorating stress disorders comprising, as an active ingredient, a lactic acid bacterium Lactobacillus delbrueckii subspecies lactis or a lactic acid bacterium-derived ingredient therefrom.

The present invention aims to provide an agent for preventing or ameliorating stress disorders, which agent is highly safe and effective, causes less side effects, and can be continuously used for a long time.

One embodiment of the present invention is an agent for preventing or ameliorating stress disorders comprising, as an active ingredient, a lactic acid bacterium Lactobacillus delbrueckii subspecies lactis or a lactic acid bacterium-derived ingredient therefrom.

The present invention relates to a transgenic plant which integrated into its genome an exogenous polynucleotide encoding a polypeptide which confers resistance to one or more races of Puccinia graminis f. sp. tritici, such as the Ug99 group of races Puccinia graminis f. sp. tritici.

The present invention relates to a transgenic plant which integrated into its genome an exogenous polynucleotide encoding a polypeptide which confers resistance to one or more races of Puccinia graminis f. sp. tritici, such as the Ug99 group of races Puccinia graminis f. sp. tritici.

The present invention relates to a pharmaceutical composition comprising a maple leaf extract or fraction thereof for preventing or treating a retinal disease, a method for preventing or treating a retinal disease using the pharmaceutical composition, and a food composition comprising a maple leaf extract or fraction thereof for ameliorating the symptoms of a retinal disease. The pharmaceutical composition according to the present invention, which is effective for the treatment of a retinal disease, can be used pharmaceutically as a composition for preventing or treating a retinal disease, and can also be used advantageously as a health functional food.

The present invention relates to use of preferably fully hydrogenated soybean oil for manufacturing a particulate feed additive that is resistant to heat induced caking The mixture of the invention comprises hydrogenated soybean oil and thymol, wherein the weight ratio between hydrogenated soybean oil and thymol is from 10:1 to 1:1 and/or wherein the mixture comprises 5-30 weight-% of thymol, based on the total weight of the mixture. Preferably, the mixture is shaped as particles by spray chilling. The particles are then used as a feed additive. The feed additive may be a premix.

The present invention relates to use of preferably fully hydrogenated soybean oil for manufacturing a particulate feed additive that is resistant to heat induced caking The mixture of the invention comprises hydrogenated soybean oil and thymol, wherein the weight ratio between hydrogenated soybean oil and thymol is from 10:1 to 1:1 and/or wherein the mixture comprises 5-30 weight-% of thymol, based on the total weight of the mixture. Preferably, the mixture is shaped as particles by spray chilling. The particles are then used as a feed additive. The feed additive may be a premix.

The present invention relates to the use of guanidinoacetic acid and a method of treating caudophagia in pigs.

The present invention relates to a method for feeding poultry during breeding, keeping or fattening of poultry, in which guanidinoacetic acid or a salt thereof is administered as a feed additive.

The present invention relates to a method for feeding poultry during breeding, keeping or fattening of poultry, in which guanidinoacetic acid or a salt thereof is administered as a feed additive.